138 related articles for article (PubMed ID: 7822786)
1. CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis.
McFarland TA; Ardman B; Manjunath N; Fabry JA; Lieberman J
J Immunol; 1995 Feb; 154(3):1097-104. PubMed ID: 7822786
[TBL] [Abstract][Full Text] [Related]
2. Enhanced susceptibility to human immunodeficiency virus infection in CD4+ T lymphocytes genetically deficient in CD43.
Srinivas RV; Su T; Trimble LA; Lieberman J; Ardman B
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1015-21. PubMed ID: 8554898
[TBL] [Abstract][Full Text] [Related]
3. CD43 interferes with T-lymphocyte adhesion.
Ardman B; Sikorski MA; Staunton DE
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5001-5. PubMed ID: 1594606
[TBL] [Abstract][Full Text] [Related]
4. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
[TBL] [Abstract][Full Text] [Related]
5. Parallel pattern of expression of CD43 and of LFA-1 on the CD45RA+ (naive) and CD45RO+ (memory) subsets of human CD4+ and CD8+ cells. Correlation with the aggregative response of the cells to CD43 monoclonal antibodies.
Youseffi-Etemad R; Axelsson B
Immunology; 1996 Mar; 87(3):439-46. PubMed ID: 8778031
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of CD43 gene enhances T lymphocyte adhesion.
Manjunath N; Johnson RS; Staunton DE; Pasqualini R; Ardman B
J Immunol; 1993 Aug; 151(3):1528-34. PubMed ID: 8335945
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakano K; Kinoshita H; Okumura A; Fujioka Y; Urakawa R; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Miyoshi E; Hirata T; Kumanogoh A; Sugiyama H; Hosen N
PLoS One; 2016; 11(3):e0152326. PubMed ID: 27011118
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes.
Jones AT; Federsppiel B; Ellies LG; Williams MJ; Burgener R; Duronio V; Smith CA; Takei F; Ziltener HJ
J Immunol; 1994 Oct; 153(8):3426-39. PubMed ID: 7523493
[TBL] [Abstract][Full Text] [Related]
9. Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.
Stöckl J; Majdic O; Kohl P; Pickl WF; Menzel JE; Knapp W
J Exp Med; 1996 Nov; 184(5):1769-79. PubMed ID: 8920865
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC
Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes.
Bazil V; Brandt J; Tsukamoto A; Hoffman R
Blood; 1995 Jul; 86(2):502-11. PubMed ID: 7605986
[TBL] [Abstract][Full Text] [Related]
13. CD43 regulates tyrosine phosphorylation of a 93-kD protein in T lymphocytes.
Manjunath N; Ardman B
Blood; 1995 Dec; 86(11):4194-8. PubMed ID: 7492777
[TBL] [Abstract][Full Text] [Related]
14. The CBF.78 monoclonal antibody to human sialophorin has distinct properties giving new insights into the CD43 marker and its activation pathway.
Tkaczuk J; Al Saati T; Escargueil-Blanc I; Salvayre A; Horejsi V; Durand M; de Preval C; Ohayon E; Delsol G; Abbal M
Tissue Antigens; 1999 Jul; 54(1):1-15. PubMed ID: 10458318
[TBL] [Abstract][Full Text] [Related]
15. Expression characteristics and stimulatory functions of CD43 in human CD4+ memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity.
Kyoizumi S; Ohara T; Kusunoki Y; Hayashi T; Koyama K; Tsuyama N
J Immunol; 2004 Jun; 172(12):7246-53. PubMed ID: 15187099
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod.
Sánchez-Mateos P; Campanero MR; del Pozo MA; Sánchez-Madrid F
Blood; 1995 Sep; 86(6):2228-39. PubMed ID: 7545023
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
Ardman B; Sikorski MA; Settles M; Staunton DE
J Exp Med; 1990 Oct; 172(4):1151-8. PubMed ID: 1976735
[TBL] [Abstract][Full Text] [Related]
18. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation.
Carlow DA; Ardman B; Ziltener HJ
J Immunol; 1999 Aug; 163(3):1441-8. PubMed ID: 10415045
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes.
Fanales-Belasio E; Zambruno G; Cavani A; Girolomoni G
J Immunol; 1997 Sep; 159(5):2203-11. PubMed ID: 9278308
[TBL] [Abstract][Full Text] [Related]
20. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43.
Axelsson B; Youseffi-Etemad R; Hammarström S; Perlmann P
J Immunol; 1988 Nov; 141(9):2912-7. PubMed ID: 3049818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
